Copyright Reports & Markets. All rights reserved.

Global Pancreatic Beta-Cell Protection Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Pancreatic Beta-Cell Protection Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Product
      • 1.4.2 Stem Cell Based
      • 1.4.3 Gene Therapies
      • 1.4.4 RNA Based Therapies
      • 1.4.5 Monoclonal Antibodies (MAbs)
      • 1.4.6 Phytotherapy
    • 1.5 Market by End User
      • 1.5.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Medical Research Laboratory
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pancreatic Beta-Cell Protection Market Size
      • 2.1.1 Global Pancreatic Beta-Cell Protection Revenue 2014-2025
      • 2.1.2 Global Pancreatic Beta-Cell Protection Sales 2014-2025
    • 2.2 Pancreatic Beta-Cell Protection Growth Rate by Regions
      • 2.2.1 Global Pancreatic Beta-Cell Protection Sales by Regions
      • 2.2.2 Global Pancreatic Beta-Cell Protection Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pancreatic Beta-Cell Protection Sales by Manufacturers
      • 3.1.1 Pancreatic Beta-Cell Protection Sales by Manufacturers
      • 3.1.2 Pancreatic Beta-Cell Protection Sales Market Share by Manufacturers
      • 3.1.3 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pancreatic Beta-Cell Protection Revenue by Manufacturers
      • 3.2.1 Pancreatic Beta-Cell Protection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pancreatic Beta-Cell Protection Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pancreatic Beta-Cell Protection Price by Manufacturers
    • 3.4 Pancreatic Beta-Cell Protection Manufacturing Base Distribution, Product Types
      • 3.4.1 Pancreatic Beta-Cell Protection Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pancreatic Beta-Cell Protection Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pancreatic Beta-Cell Protection Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pancreatic Beta-Cell Protection Sales by Product
    • 4.2 Global Pancreatic Beta-Cell Protection Revenue by Product
    • 4.3 Pancreatic Beta-Cell Protection Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pancreatic Beta-Cell Protection Breakdown Data by End User

    6 North America

    • 6.1 North America Pancreatic Beta-Cell Protection by Countries
      • 6.1.1 North America Pancreatic Beta-Cell Protection Sales by Countries
      • 6.1.2 North America Pancreatic Beta-Cell Protection Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pancreatic Beta-Cell Protection by Product
    • 6.3 North America Pancreatic Beta-Cell Protection by End User

    7 Europe

    • 7.1 Europe Pancreatic Beta-Cell Protection by Countries
      • 7.1.1 Europe Pancreatic Beta-Cell Protection Sales by Countries
      • 7.1.2 Europe Pancreatic Beta-Cell Protection Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pancreatic Beta-Cell Protection by Product
    • 7.3 Europe Pancreatic Beta-Cell Protection by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pancreatic Beta-Cell Protection by Countries
      • 8.1.1 Asia Pacific Pancreatic Beta-Cell Protection Sales by Countries
      • 8.1.2 Asia Pacific Pancreatic Beta-Cell Protection Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pancreatic Beta-Cell Protection by Product
    • 8.3 Asia Pacific Pancreatic Beta-Cell Protection by End User

    9 Central & South America

    • 9.1 Central & South America Pancreatic Beta-Cell Protection by Countries
      • 9.1.1 Central & South America Pancreatic Beta-Cell Protection Sales by Countries
      • 9.1.2 Central & South America Pancreatic Beta-Cell Protection Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pancreatic Beta-Cell Protection by Product
    • 9.3 Central & South America Pancreatic Beta-Cell Protection by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pancreatic Beta-Cell Protection by Countries
      • 10.1.1 Middle East and Africa Pancreatic Beta-Cell Protection Sales by Countries
      • 10.1.2 Middle East and Africa Pancreatic Beta-Cell Protection Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pancreatic Beta-Cell Protection by Product
    • 10.3 Middle East and Africa Pancreatic Beta-Cell Protection by End User

    11 Company Profiles

    • 11.1 ViaCyte
      • 11.1.1 ViaCyte Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 ViaCyte Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 ViaCyte Pancreatic Beta-Cell Protection Products Offered
      • 11.1.5 ViaCyte Recent Development
    • 11.2 PharmaCyte Biotech
      • 11.2.1 PharmaCyte Biotech Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 PharmaCyte Biotech Pancreatic Beta-Cell Protection Products Offered
      • 11.2.5 PharmaCyte Biotech Recent Development
    • 11.3 Boehringer Ingelheim
      • 11.3.1 Boehringer Ingelheim Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boehringer Ingelheim Pancreatic Beta-Cell Protection Products Offered
      • 11.3.5 Boehringer Ingelheim Recent Development
    • 11.4 GalaxoSmithKline
      • 11.4.1 GalaxoSmithKline Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GalaxoSmithKline Pancreatic Beta-Cell Protection Products Offered
      • 11.4.5 GalaxoSmithKline Recent Development
    • 11.5 Beta-Cell NV
      • 11.5.1 Beta-Cell NV Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Beta-Cell NV Pancreatic Beta-Cell Protection Products Offered
      • 11.5.5 Beta-Cell NV Recent Development
    • 11.6 Novartis
      • 11.6.1 Novartis Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Novartis Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Novartis Pancreatic Beta-Cell Protection Products Offered
      • 11.6.5 Novartis Recent Development
    • 11.7 Janssen Research & Development
      • 11.7.1 Janssen Research & Development Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Janssen Research & Development Pancreatic Beta-Cell Protection Products Offered
      • 11.7.5 Janssen Research & Development Recent Development
    • 11.8 Pfizer Inc
      • 11.8.1 Pfizer Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Inc Pancreatic Beta-Cell Protection Products Offered
      • 11.8.5 Pfizer Inc Recent Development
    • 11.9 BioLineRx
      • 11.9.1 BioLineRx Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 BioLineRx Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 BioLineRx Pancreatic Beta-Cell Protection Products Offered
      • 11.9.5 BioLineRx Recent Development
    • 11.10 Genentech
      • 11.10.1 Genentech Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Genentech Pancreatic Beta-Cell Protection Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Genentech Pancreatic Beta-Cell Protection Products Offered
      • 11.10.5 Genentech Recent Development
    • 11.11 Novo Nordisk
    • 11.12 Sanofi
    • 11.13 Osiris Therapeutics
    • 11.14 Beta-O2 Technologies Ltd
    • 11.15 Transition Therapeutics

    12 Future Forecast

    • 12.1 Pancreatic Beta-Cell Protection Market Forecast by Regions
      • 12.1.1 Global Pancreatic Beta-Cell Protection Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pancreatic Beta-Cell Protection Revenue Forecast by Regions 2019-2025
    • 12.2 Pancreatic Beta-Cell Protection Market Forecast by Product
      • 12.2.1 Global Pancreatic Beta-Cell Protection Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pancreatic Beta-Cell Protection Revenue Forecast by Product 2019-2025
    • 12.3 Pancreatic Beta-Cell Protection Market Forecast by End User
    • 12.4 North America Pancreatic Beta-Cell Protection Forecast
    • 12.5 Europe Pancreatic Beta-Cell Protection Forecast
    • 12.6 Asia Pacific Pancreatic Beta-Cell Protection Forecast
    • 12.7 Central & South America Pancreatic Beta-Cell Protection Forecast
    • 12.8 Middle East and Africa Pancreatic Beta-Cell Protection Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pancreatic Beta-Cell Protection Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Pancreatic Beta-Cell Protection market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pancreatic Beta-Cell Protection market based on company, product type, end user and key regions.

      This report studies the global market size of Pancreatic Beta-Cell Protection in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pancreatic Beta-Cell Protection in these regions.
      This research report categorizes the global Pancreatic Beta-Cell Protection market by top players/brands, region, type and end user. This report also studies the global Pancreatic Beta-Cell Protection market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      ViaCyte
      PharmaCyte Biotech
      Boehringer Ingelheim
      GalaxoSmithKline
      Beta-Cell NV
      Novartis
      Janssen Research & Development
      Pfizer Inc
      BioLineRx
      Genentech
      Novo Nordisk
      Sanofi
      Osiris Therapeutics
      Beta-O2 Technologies Ltd
      Transition Therapeutics

      Market size by Product
      Stem Cell Based
      Gene Therapies
      RNA Based Therapies
      Monoclonal Antibodies (MAbs)
      Phytotherapy
      Market size by End User
      Hospital
      Medical Research Laboratory
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Pancreatic Beta-Cell Protection market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Pancreatic Beta-Cell Protection market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Pancreatic Beta-Cell Protection companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Pancreatic Beta-Cell Protection submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Pancreatic Beta-Cell Protection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pancreatic Beta-Cell Protection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now